Cargando…
Immunogenicity of small‐cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition
INTRODUCTION: The activation of STING (stimulator of interferon genes) pathway enhances antitumor immunity in small‐cell lung cancer (SCLC), while the DNA damage induced by non‐cGAMP‐based agonists is a potent inducer of STING activity. Here, we investigate the intrinsic expression of STING in cance...
Autores principales: | Li, Xuetao, Li, Yujun, Zhao, Ziwen, Miao, Nabo, Liu, Guorong, Deng, Liaoyuan, Wei, Shuquan, Hou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972012/ https://www.ncbi.nlm.nih.gov/pubmed/35957613 http://dx.doi.org/10.1002/cam4.5109 |
Ejemplares similares
-
Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific
por: Li, Xuetao, et al.
Publicado: (2023) -
Genomic features of Chinese small cell lung cancer
por: Liu, Jun, et al.
Publicado: (2022) -
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
por: Schultz, Christopher W, et al.
Publicado: (2023) -
Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer
por: Liu, Chaofan, et al.
Publicado: (2023) -
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
por: Yoshida, Ryohei, et al.
Publicado: (2022)